Icon

XIMINO (nda201922)- (EQ 45MG BASE,EQ 67.5MG BASE,EQ 90MG BASE,EQ 112.5MG BASE,EQ 135MG BASE)

MINOCYCLINE HYDROCHLORIDE JOURNEY
EQ 45MG BASE,EQ 67.5MG BASE,EQ 90MG BASE,EQ 112.5MG BASE,EQ 135MG BASE
No Yes
2027-Apr-02 Expired
None None
None No
Ximino is a tetracycline-class drug indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 45MG BASE ** ** - - -
EQ 67.5MG BASE ** ** - - -
EQ 90MG BASE ** ** - - -
EQ 112.5MG BASE ** ** - - -
EQ 135MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.